Business Description
Guangdong Bawei Biotechnology Corp
ISIN : CNE100006FQ7
Total Employee Number:
1,119Compare
Compare
Traded in other countries / regions
920123.China IPO Date
2024-03-29Description
Guangdong Bawei Biotechnology Corp is engaged in Research, development, production, sales and testing of cosmetics.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.32 | |||||
Equity-to-Asset | 0.48 | |||||
Debt-to-Equity | 0.53 | |||||
Debt-to-EBITDA | 4.62 | |||||
Interest Coverage | 12.35 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 3.05 | |||||
Beneish M-Score | -2.83 | |||||
WACC vs ROIC | ||||||
Growth Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 17.9 | |||||
3-Year EBITDA Growth Rate | -4.3 | |||||
3-Year EPS without NRI Growth Rate | 0.3 | |||||
3-Year FCF Growth Rate | 22.7 | |||||
3-Year Book Growth Rate | 5.8 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 66.56 | |||||
9-Day RSI | 59.04 | |||||
14-Day RSI | 56.07 | |||||
3-1 Month Momentum % | -5.65 | |||||
6-1 Month Momentum % | -29.8 | |||||
12-1 Month Momentum % | -43.72 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.21 | |||||
Quick Ratio | 0.89 | |||||
Cash Ratio | 0.25 | |||||
Days Inventory | 46.73 | |||||
Days Sales Outstanding | 51.75 | |||||
Days Payable | 63.28 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Yield % | 1.83 | |||||
Dividend Payout Ratio | 0.49 | |||||
Forward Dividend Yield % | 1.83 | |||||
5-Year Yield-on-Cost % | 1.83 | |||||
3-Year Average Share Buyback Ratio | -3.9 | |||||
Shareholder Yield % | -0.56 |
Profitability Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 22.96 | |||||
Operating Margin % | 7.33 | |||||
Net Margin % | 4.41 | |||||
EBITDA Margin % | 5.4 | |||||
FCF Margin % | 7.59 | |||||
OCF Margin % | 14.99 | |||||
ROE % | 9.76 | |||||
ROA % | 4.64 | |||||
ROIC % | 9.69 | |||||
3-Year ROIIC % | 4.86 | |||||
ROC (Joel Greenblatt) % | 12.12 | |||||
ROCE % | 8.3 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 29.97 | |||||
PE Ratio without NRI | 23.18 | |||||
Shiller PE Ratio | 25.73 | |||||
PEG Ratio | 2.52 | |||||
PS Ratio | 1.38 | |||||
PB Ratio | 2.86 | |||||
Price-to-Tangible-Book | 3.1 | |||||
Price-to-Free-Cash-Flow | 20.96 | |||||
Price-to-Operating-Cash-Flow | 9.6 | |||||
EV-to-EBIT | 28.04 | |||||
EV-to-EBITDA | 28.04 | |||||
EV-to-Revenue | 1.52 | |||||
EV-to-FCF | 19.96 | |||||
Price-to-Projected-FCF | 3.51 | |||||
Price-to-Peter-Lynch-Fair-Value | 2.66 | |||||
Price-to-Graham-Number | 1.79 | |||||
Earnings Yield (Greenblatt) % | 3.57 | |||||
FCF Yield % | 5.65 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Guangdong Bawei Biotechnology Corp Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 907.101 | ||
| EPS (TTM) (Â¥) | 0.365 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | 34.93 | ||
| 14-Day RSI | 56.07 | ||
| 14-Day ATR (Â¥) | 0.463815 | ||
| 20-Day SMA (Â¥) | 10.6805 | ||
| 12-1 Month Momentum % | -43.72 | ||
| 52-Week Range (Â¥) | 9 - 21.82 | ||
| Shares Outstanding (Mil) | 111.54 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Guangdong Bawei Biotechnology Corp Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Guangdong Bawei Biotechnology Corp Stock Events
| Event | Date | Price (Â¥) | ||
|---|---|---|---|---|
| CNY 0.200000 Cash Dividend | 2026-05-29 | 11.16 (-0.09%) | ||
| CNY 0.230769 Cash Dividend | 2025-05-28 | 22.27 (+3.73%) | ||
| 1.3:1 Stock Split | 2025-05-28 | 22.27 (+3.73%) |
Show
Entries
Guangdong Bawei Biotechnology Corp Frequently Asked Questions
What is Guangdong Bawei Biotechnology Corp(BJSE:920123)'s stock price today?
The current price of BJSE:920123 is ¥10.94. The 52 week high of BJSE:920123 is ¥21.82 and 52 week low is ¥9.00.
When is next earnings date of Guangdong Bawei Biotechnology Corp(BJSE:920123)?
The next earnings date of Guangdong Bawei Biotechnology Corp(BJSE:920123) is .
Does Guangdong Bawei Biotechnology Corp(BJSE:920123) pay dividends? If so, how much?
The Dividend Yield %  of Guangdong Bawei Biotechnology Corp(BJSE:920123) is 1.83% (As of Today), Highest Dividend Payout Ratio of Guangdong Bawei Biotechnology Corp(BJSE:920123) was 0.52. The lowest was 0.24. And the median was 0.38. The  Forward Dividend Yield % of Guangdong Bawei Biotechnology Corp(BJSE:920123) is 1.83%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Guangdong Bawei Biotechnology Corp
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers